Application of RNase1 has also been discussed as an antitumoral agent; RNase1 administration reduced tumor volume and weight, and increased the area of necrosis in vivo in xenograft mice models (Fischer et al., 2013; Zakrzewicz et al., 2016). This evidence concerns the gene RNASE1 and neoplasm.